ArticleBreast cancer (Dove Medical Press)2025

Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker.

Yuting Gou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.